Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Decreased EDSS after plasma exchange in NMOSD Next Article
Long-term safety and efficacy of ozanimod in relapsing MS »
« Decreased EDSS after plasma exchange in NMOSD Next Article
Long-term safety and efficacy of ozanimod in relapsing MS »
Table of Contents: ECF 2020
Featured articles
ECF Round-Up Articles
No association between Ig levels and infection in ofatumumab-treated patients with relapsing MS
Defining phenotypes of MS-related cognitive impairment
First long-term efficacy data of a BTK inhibitor
Novel disease-specific scale confirms huge impact of fatigue
Progressive aerobic exercise improves fatigue
Reliable and convenient method to assess cognitive function in MS patients
Tackling unmet MS-related cognitive challenges
Real-world efficacy of ocrelizumab in MS patients
Similar demographics, clinical characteristics, and treatment patterns in German claims study
Decreased EDSS after plasma exchange in NMOSD
No support for IVIG as treatment of acute attacks in NMOSD
Related Articles
December 16, 2020
No increased risk with IFN-β use during pregnancy
December 16, 2020
Defining phenotypes of MS-related cognitive impairment
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy